New foam could clear eczema in weeks
NCT ID NCT07173478
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 19 times
Summary
This study tests a medicated foam (1% OPA-15406) for adults with atopic dermatitis (eczema). About 156 people with mild to moderate eczema will use the foam or a placebo for 4 weeks. The goal is to see if the foam can clear or nearly clear the skin better than the placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-••••
Locations
-
Mita Dermatology Clinic
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.